Russell 2000 Index Newsroom

Blend Labs Analyst Ratings

Benzinga2minutes ago · Ratings

Q2 Holdings Analyst Ratings

Benzinga8minutes ago · Ratings

Agenus Announced Five Presentations Featuring Botensilimab (Bot, An Fc-enhanced Anti-CTLA-4 Antibody) Plus Balstilimab (Bal, An Anti-PD-1 Antibody) At The Upcoming American Society Of Clinical Oncology Gastrointestinal Cancers Symposium

Benzinga8minutes ago

Solid Power, Ford Extend Battery Development Deal

Seeking Alpha21minutes ago

LiveOne-Tesla Partnership Hits 350K Paid Subscribers, Highlights $16M Cash Position

Benzinga25minutes ago

Academy Sports Analyst Ratings

Benzinga39minutes ago · Ratings

Baird Downgrades Fluor to Neutral, Raises Price Target to $58

Benzinga40minutes ago · Ratings

The European Commission Has Adopted A Positive Decision For The Designation Of Agios Pharmaceuticals' Mitapivat As An Orphan Medicinal Product For Sickle Cell Disease

Benzinga40minutes ago

Fluor Analyst Ratings

Benzinga41minutes ago · Ratings

Forecasting The Future: 12 Analyst Projections For Fluence Energy

Benzinga43minutes ago

Transocean Analyst Ratings

Benzinga44minutes ago · Ratings

Oceaneering International Analyst Ratings

Benzinga47minutes ago · Ratings

Krystal Biotech Analyst Ratings

Benzinga58minutes ago · Ratings

JP Morgan Downgrades Getty Images Holdings to Underweight

Benzinga06:32 ET

Compass Pathways Common Stock To Be Added To The Nasdaq Biotechnology Index

Benzinga06:31 ET

Getty Images Holdings Analyst Ratings

Benzinga06:31 ET · Ratings

Xometry Analyst Ratings

Benzinga06:27 ET · Ratings

Rocket Pharmaceuticals Analyst Ratings

Benzinga06:22 ET · Ratings

Foot Locker Analyst Ratings

Benzinga06:16 ET · Ratings

Halozyme Therapeutics Analyst Ratings

Benzinga06:14 ET · Ratings